A drug that inhibits the molecule known as prostaglandin E2 (PGE2) increased survival rates in mice infected with a lethal dose of the H1N1 flu virus.
The USGS and CDC have found antibodies for the 2009 H1N1 flu virus in blood samples from 70% of the sea otters studied
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the most common cause of admission in children under the age of 1.
A 3-D laboratory method has been developed to test asthma and allergy medications that could reduce the need to test the drugs on animals.
Two cell surface receptors might be responsible for the most common form of lung cancer spreading to other parts of the body, according to a study led by the Translational Genomics Research Institute (TGen).
A rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections, according to a National Institutes of Health (NIH) study published in The New England Journal of Medicine.
The drug sirolimus slows progression of a severe and progressive lung disease called lymphangioleiomyomatosis (LAM), but the drug can cause fatal complications for those patients needing lung transplant.
On average nationally, people of color are exposed to 38 percent higher levels of nitrogen dioxide (NO2) outdoor air pollution compared to white people, and the gap is associated with higher deaths from heart disease for non-whites.
A study reveals a minimal set of mutations allowing H5N1 to be transmitted through the air from one ferret to another. The findings will be invaluable for future surveillance programs and may provide warning signals of the emergence of potential pandemic strains.
Spacelabs Healthcare is recalling the Arkon Anesthesia System with Version 2.0 Software due to a software defect that may cause serious adverse health consequences, including hypoxemia and death, according to an FDA announcement.